DE60033183D1 - Transplantatabstossung und damit verbundene zustände - Google Patents

Transplantatabstossung und damit verbundene zustände

Info

Publication number
DE60033183D1
DE60033183D1 DE60033183T DE60033183T DE60033183D1 DE 60033183 D1 DE60033183 D1 DE 60033183D1 DE 60033183 T DE60033183 T DE 60033183T DE 60033183 T DE60033183 T DE 60033183T DE 60033183 D1 DE60033183 D1 DE 60033183D1
Authority
DE
Germany
Prior art keywords
associated states
transplant delivery
transplant
delivery
transducin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60033183T
Other languages
English (en)
Other versions
DE60033183T2 (de
Inventor
Lydia Rose Marlene
John Dunn Michael
Linke Adam
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ip2ipo Innovations Ltd
Original Assignee
Imperial Innovations Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Imperial Innovations Ltd filed Critical Imperial Innovations Ltd
Publication of DE60033183D1 publication Critical patent/DE60033183D1/de
Application granted granted Critical
Publication of DE60033183T2 publication Critical patent/DE60033183T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Diabetes (AREA)
  • Rehabilitation Therapy (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Rheumatology (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Peptides Or Proteins (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Medicines Containing Plant Substances (AREA)
DE60033183T 1999-11-29 2000-11-29 Transplantatabstossung und damit verbundene zustände Expired - Lifetime DE60033183T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9928136 1999-11-29
GBGB9928136.2A GB9928136D0 (en) 1999-11-29 1999-11-29 Organ rejection and associated conditions
PCT/GB2000/004553 WO2001040302A2 (en) 1999-11-29 2000-11-29 Organ transplant rejection and associated conditions

Publications (2)

Publication Number Publication Date
DE60033183D1 true DE60033183D1 (de) 2007-03-15
DE60033183T2 DE60033183T2 (de) 2007-11-08

Family

ID=10865318

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60033183T Expired - Lifetime DE60033183T2 (de) 1999-11-29 2000-11-29 Transplantatabstossung und damit verbundene zustände

Country Status (10)

Country Link
US (1) US7132245B2 (de)
EP (1) EP1242450B1 (de)
AT (1) ATE352563T1 (de)
AU (1) AU780041B2 (de)
CA (1) CA2390778C (de)
DE (1) DE60033183T2 (de)
DK (1) DK1242450T3 (de)
ES (1) ES2281364T3 (de)
GB (1) GB9928136D0 (de)
WO (1) WO2001040302A2 (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018614D0 (en) * 2000-07-28 2000-09-13 Rose Marlene L Organ transplant rejection and associated conditions
US6905827B2 (en) 2001-06-08 2005-06-14 Expression Diagnostics, Inc. Methods and compositions for diagnosing or monitoring auto immune and chronic inflammatory diseases
US7235358B2 (en) 2001-06-08 2007-06-26 Expression Diagnostics, Inc. Methods and compositions for diagnosing and monitoring transplant rejection
US20070243561A1 (en) * 2006-02-16 2007-10-18 Ben Geeraerts Prognostic markers in chronic lymphocytic leukemia
US8735178B2 (en) * 2006-03-27 2014-05-27 University Of Kentucky Research Foundation Withanolides, probes and binding targets and methods of use thereof
WO2008151146A2 (en) * 2007-06-01 2008-12-11 Digitab, Inc. Peptide arrays and methods of use
WO2015102341A1 (ko) * 2013-12-30 2015-07-09 재단법인 의약바이오컨버젼스연구단 항 krs 모노클로날 항체 및 이의 용도
WO2018182284A1 (ko) * 2017-03-27 2018-10-04 재단법인 의약바이오컨버젼스연구단 세포 외막에 노출되는 라이실-tRNA 합성효소 N-말단 영역에 특이적으로 결합하는 항체
RU2739393C1 (ru) 2017-03-27 2020-12-23 БайоконТАК Ко., Лтд. АНТИТЕЛО, СПЕЦИФИЧЕСКИ СВЯЗЫВАЮЩЕЕСЯ C N-КОНЦЕВОЙ ОБЛАСТЬЮ ЛИЗИЛ-тРНК-СИНТЕТАЗЫ, ЭКСПОНИРОВАННОЙ НА КЛЕТОЧНОЙ МЕМБРАНЕ
CA3084461A1 (en) 2017-09-15 2019-03-21 Medicinal Bioconvergence Research Center Pharmaceutical composition comprising antibody binding specifically to lysyl-trna synthetase n-terminus as effective ingredient for preventing or treating immune cell migration-related disease
EP3882272A4 (de) * 2018-09-17 2022-10-12 Zymedi Co., Ltd. Antikörper zur spezifischen bindung an eine gegenüber der extrazellulären membran exponierte n-terminale domäne der lysyl-trna-synthetase

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2268935B (en) 1992-06-24 1996-10-23 Nat Heart & Lung Inst Diagnosis of rejection of transplanted organs
GB0018614D0 (en) 2000-07-28 2000-09-13 Rose Marlene L Organ transplant rejection and associated conditions

Also Published As

Publication number Publication date
CA2390778C (en) 2010-06-15
ATE352563T1 (de) 2007-02-15
EP1242450B1 (de) 2007-01-24
WO2001040302A2 (en) 2001-06-07
WO2001040302A3 (en) 2002-03-21
US20050277157A1 (en) 2005-12-15
DE60033183T2 (de) 2007-11-08
AU780041B2 (en) 2005-02-24
CA2390778A1 (en) 2001-06-07
AU1717301A (en) 2001-06-12
EP1242450A2 (de) 2002-09-25
US7132245B2 (en) 2006-11-07
DK1242450T3 (da) 2007-05-29
ES2281364T3 (es) 2007-10-01
GB9928136D0 (en) 2000-01-26

Similar Documents

Publication Publication Date Title
DK2316852T3 (da) Stabiliserede enkeltdomæne-antistoffer
DE60033183D1 (de) Transplantatabstossung und damit verbundene zustände
EP2112167A3 (de) Humanisierte ANTI-ERBB2-Antikörper und Behandlung mit ANTI-ERBB2-Antikörpern
DK1356052T3 (da) Produktion af hele antistoffer i prokaryotiske celler
ATE446366T1 (de) Agonistische monoklonale antikörper gegen trkc
TR199902818T2 (xx) Be�eri kullan�m i�in antikorlar ve be�eri kullan�m i�in antikorlar olu�turmak i�in y�ntemler.
NL300418I1 (nl) Gebruik van trifunctionele bispecifieke en trispecifieke antilichamen voor de behandeling van maligne ascitis
EA200700083A1 (ru) Антитела, направленные против бета-амилоидного пептида, и способы их применения
WO2004041865A3 (en) Stabilized single domain antibodies
EP2281568A3 (de) Verwendung von löslichen mutanten CTLA4-Mutantenmolekülen
EP2316486A3 (de) Cripto-blockierende Antikörper und ihre Verwendung
WO2004066957A3 (en) ANTI-INTEGRIN ανβ3 ANTIBODY FORMULATIONS AND USES THEREOF
EE05558B1 (et) Antikeha v?i selle antigeeni siduva fragmendi v?i lahustuva polpeptiidi kasutamine farmatseutilise kompositsiooni valmistamiseks
WO2004030622A3 (en) Method of isolation and self-assembly of small protein particles from blood and other biological materials
ATE336506T1 (de) Verwendung löslicher cytokeratin-1-fragmente in diagnostik
ATE235551T1 (de) Ligand (tie ligand-4) vom tie-2 rezeptor und dessen verwendungen
WO2002077176A3 (en) Aberrantly expressed proteins in laser capture microdissected tumors
RS20100249A (en) CONJUGATES AND PROCEDURES FOR THEIR PRODUCTION, AND THEIR USE FOR THE TRANSPORT OF MOLECULES THROUGH BIOLOGICAL MEMBRANE
DE60132443D1 (de) In lebenden zielzellen
DE60133104D1 (de) Verfahren und zusammensetzungen zur behandlung von neoplastischen erkrankungen mittels chemotherapie und strahlungssensibilisatoren
WO2004069860A3 (en) Isg15-conjugated proteins
ATE306668T1 (de) Diagnose von brustkrebs unter verwendung von bcmp-7 als marker
WO2004083241A3 (en) Btc-interacting proteins and use thereof
WO2005094159A3 (en) Methods of identifying neoplasm-specific antibodies and uses thereof
JP2005523891A5 (de)

Legal Events

Date Code Title Description
8364 No opposition during term of opposition